MENU

Current Diabetes Research Studies

Have you been diagnosed with Type 2 Diabetes and are interested in participating in a research study?

ECU Diabetes Research Center is participating in a trial comparing the efficacy and safety of insulin degludec and insulin glargine 300 units/mL in subjects with type 2 diabetes mellitus inadequately treated with basal insulin with or without oral anti-diabetic drugs.

What is this research study about?

To compare the effects of Troujeo and Tresiba on hypoglycemic events

How long will it take and what do I have to do?

The research study will take 1 year

Participants will need to be over 18 years old, not using bolus insulin, check their blood sugars, follow the protocol and timeline provided for medication adjustments, phone calls, and clinic visits.

What are potential benefits in taking part in this research study?

Decreased Hypoglycemic events

  • Diligent monitoring and medication adjustments may help decrease the frequency and severity of hypoglycemic occurrences.

Improved Glycemic Control (Blood Glucose Control)

  • You may experience improvement in your blood sugar control.

Free Medicines and testing supplies

  • Study medicines and blood glucose testing supplies will be provided during the research study.

Who's running this research study?

The research study is being run by the ECU Diabetes Research Center.

The Primary Investigator is Dr. Robert Tanenberg


Download Research Participants flyer (pdf)